These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2866396)

  • 1. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S; Thomas HC
    Lancet; 1985 Dec; 2(8468):1343-6. PubMed ID: 2866396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the treatment of chronic hepatitis B viral infection.
    Thomas HC; Lok AS
    Prog Clin Biol Res; 1983; 143():379-93. PubMed ID: 6199798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S129-35. PubMed ID: 2439569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
    Guerre J; Gaudric M; Couturier D; Levy C
    Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
    Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic anti-HBe positive chronic hepatitis B in Taiwan with special reference to persistent HBV replication and HDV superinfection.
    Wu JC; Lee SD; Tsay SH; Tsai YT; Chan CY; Huang YS; Lo KJ; Ting LP
    J Med Virol; 1988 Jun; 25(2):141-8. PubMed ID: 3392522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
    Schalm SW
    Chemioterapia; 1988 Dec; 7 Suppl 3():26-9. PubMed ID: 3248317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic viral hepatitis.
    Marcellin P; Benhamou JP
    Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriers.
    Actis GC; Maran E; Saracco G; Rosina F; Brunetto MR; Baldi M; Lattore V; Rocca G; Bonino F; Rizzetto M
    Ric Clin Lab; 1987; 17(4):331-41. PubMed ID: 3438668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.